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Abstract
Population-scale genome sequencing allows the characterization of functional effects of a broad spectrum of genetic
variants underlying human phenotypic variation. Here, we investigate the influence of rare and common genetic variants on
gene expression patterns, using variants identified from sequencing data from the 1000 genomes project in an African and
European population sample and gene expression data from lymphoblastoid cell lines. We detect comparable numbers of
expression quantitative trait loci (eQTLs) when compared to genotypes obtained from HapMap 3, but as many as 80% of the
top expression quantitative trait variants (eQTVs) discovered from 1000 genomes data are novel. The properties of the
newly discovered variants suggest that mapping common causal regulatory variants is challenging even with full
resequencing data; however, we observe significant enrichment of regulatory effects in splice-site and nonsense variants.
Using RNA sequencing data, we show that 46.2% of nonsynonymous variants are differentially expressed in at least one
individual in our sample, creating widespread potential for interactions between functional protein-coding and regulatory
variants. We also use allele-specific expression to identify putative rare causal regulatory variants. Furthermore, we
demonstrate that outlier expression values can be due to rare variant effects, and we approximate the number of such
effects harboured in an individual by effect size. Our results demonstrate that integration of genomic and RNA sequencing
analyses allows for the joint assessment of genome sequence and genome function.
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Introduction
Deeper characterization of genetic variation is becoming
increasingly available with advances in DNA sequencing technol-
ogy [1–5]. This improves our ability to pinpoint protein-coding
variants which disrupt protein structure, and has already begun to
provide insight into the genetic basis of disease with unknown
etiology [6,7]. In addition to protein-coding variation, access to a
more complete spectrum of genetic data facilitates the discovery of
regulatory variants. However, relative to protein coding variation,
the information about the structure of gene regulatory architecture
is incomplete and the existence of a regulatory variant is largely
inferred through its association with gene expression. Such asso-
ciations have previously been identified as exhibiting widespread
and tissue-specific patterns [8–11]. They are also increasingly linked
to the basis of human phenotypic diversity [11]. For instance, recent
studies have implicatedthe role of regulatoryvariants in the etiology
of diseases such as obesity [12], celiac disease [13] and migraine
[14]. Now, the compendium of variants acquired from genome
sequencing of population samples provides increased potential for
uncovering new associations, many of which, given this enhanced
resolution, are presumed to be causal. Furthermore, we are able
to begin to analyse genome-wide signals of interactions between
disruptive protein-coding variation and regulatory variation. We
investigate the landscape of regulatory variation as surveyed by
population-scale sequencing by using data acquired from the 1000
genomes project, together with gene expression data in 60 CEU
individuals (CEU: Utah residents with ancestry from northern and
western Europe) acquired using RNA sequencing (RNA-Seq) and
57 CEU and 56 YRI individuals (YRI: Yoruba in Ibadan, Nigeria)
acquired using gene expression arrays [15,16]. In this study, we
demonstrate the value of almost complete information from the




We assessed the number of expression quantitative trait loci
within 1 Mb of annotated genes (cis-eQTLs), and compared the
power of HapMap3 (HM3) against the much higher SNP density
of the 1000 genomes project (1KG) genetic variants, using gene
expression data from lymphoblastoid cells for matching individuals
(see Materials and Methods). For both CEU and YRI, similar
numbers of eQTLs were found between the two projects in-
dependent of FDR (estimated by permutations; Figure 1 and
Figure S1). This suggests that, with given power, the majority of
the common regulatory effects can be captured by genome-wide
SNP arrays. Using RNA sequencing data, we were also able to
survey the difference between 1KG and HM3 for regulatory
variation detected through allelic imbalance of heterozygous
coding sites. In 1KG, twice as many heterozygous sites (36015
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reviewed [17]) effect (p#0.05), corresponding to 4971 genes versus
3175 genes. The median log effect size for this imbalance was 1.39
(Figure S2). This increase provides more power to explore within
individual regulatory variation.
Given that the 1KG data provides an almost complete ascer-
tainment of common SNPs, we sought to assess whether we are
more likely to detect potentially causal regulatory variants. We
observed that nearly 80% of all eQTVs discovered with the 1KG
were not discovered with the HM3 (Table S1). This indicates that
if these new variants are bonafide causal variants, whole genome
sequencing is uncovering a large number of previously unidenti-
fied variants. Conversely, however, for the eQTVs discovered with
the HM3, up 65% would not have passed the discovery threshold
in the 1KG due to the extra multiple testing correction implicit
through having 5–7 times as many variants (Table S2). In order to
investigate if the 1KG eQTLs exhibited characteristics indicative
of being a functional variant, we fine mapped HM3-discovered
eQTLs into the 1KG (see Materials and Methods). We observed
that for both populations, independent of the gene expression
platform, the majority of these HM3 eQTLs were found in the
1KG with the same or a different variant of higher significance,
and infrequently (,16%) would the association be worse, likely
Author Summary
The recent availability of almost fully sequenced human
genomes by the 1000 genomes project allows the direct
study of genetic variants that influence levels of gene
expression in the cell. In this study, we explore the effect of
rare and common variants on levels of gene expression.
We show that the availability of a more comprehensive list
of variants brings us closer to the likely causal variants, and
we discuss their genomic and evolutionary properties. We
also demonstrate the effects of variants that change
splicing patterns or length of the protein product, the
putative joint impacts of variants that affect gene
expression, and those that affect protein structure. Finally,
we show the impact of rare regulatory variants that cannot
be detected by the conventional methodologies of
association and require the interrogation of full genome
sequencing and full transcriptome sequencing. These
approaches bring us closer to the implementation of
these data and methodologies to a direct clinical
application.
Figure 1. Comparison of eQTL discovery in HapMap 3 and 1000 genomes project data. We compared the discovery of eQTLs from
HapMap 3 (black) and 1000 genomes (red) project variants by expression platform (LCL expression interrogated on arrays from 56 Africans and 57
Europeans, and by RNA sequencing of 60 Europeans) across log-mean permutation threshold. At all levels of FDR across the permutation threshold
range, we observe similar levels of detection of eQTL genes between HapMap 3 SNPs and 1000 genomes project SNPs. This indicates that given our
sample sizes, similar levels of regulatory haplotypes are recovered despite the 5–76 increase in the number of common variants from DNA-
sequencing. Comparison relative to observed p-value instead of FDR (Figure S1) accentuates the effect of increased number of tests in the 1000
genomes project data. Furthermore, the comparison between array and RNA sequencing data shows a reduction in the FDR relative to the total
number of genes for relaxed permutation thresholds, indicating improved performance of the platform to uncover eQTLs in this FDR range.
doi:10.1371/journal.pgen.1002144.g001
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compared the properties of these eQTLs in HM3 and 1KG. Since
previous analyses have identified a strong enrichment of eQTLs
around the transcription start site [18–20], we investigated if the
1KG associated SNPs were more proximal to the transcription
start site of their associated gene than the HM3 associated SNPs,
but no significant trend was observed (Figures S3, S4 and S5). This
supports recent observations that the strongest effects on gene
expression are not exclusively defined through promoter variation
[15,21]. We next asked if the newly discovered variants were on
more evolutionarily conserved sites, which would suggest that they
are more likely to be causal variants [22]. In this analysis we had to
account for the fact that the HM3 SNPs are more conserved
overall (Student’s T-test p,2e-16; MW p,2e-16). Thus, we
compared the within platform difference between the best
association and the second best-linked association, expecting that
the increase in conservation between the two could be higher
within 1KG due to the best association being more often the
causal variant than in HM3. However, no significant difference
was observed (Figure S6), which indicates, consistent with
ENCODE findings, that many regulatory elements and thus also
genetic variants in these elements are unconstrained [23,24].
eQTLs for alternative splicing
We investigated the allelic expression properties of transcript
variants that have a putative impact on transcript structure. For
splicing variants (MAF$5%), we saw an enrichment in associa-
tions in RNA-Seq data for the respective donor and acceptor exon
read count levels (the number of RNA sequencing reads which
overlap the exon for an individual, see Materials and Methods)
compared to a background derived from synonymous variants
(Figure S7). This enrichment was observed independent of
Figure 2. Fine mapping of HapMap 3 eQTLs into 1000 genomes variants. For eQTLs discovered with HapMap 3 (HM3) variants we assessed
the best p-value of a variant in linkage disequilibrium (D9$0.8) with the HapMap 3 variant in the 1000 genomes (1KG). This discovery was compared
for all populations and expression platforms and in between exon and gene eQTLs for the RNA-Seq data. We found that usually a better association
was uncovered in 1KG, suggesting that we are more likely to be observing the causal variant. For CEU-eQTLs (top right panel) discovered using arrays,
189 of 398 associations were better in the 1000 genomes (only 34 worse). For YRI-eQTLs (top left panel) discovered using arrays, 187 of 427
associations were better in the 1000 genomes (28 worse). For CEU gene and exon-eQTLs discovered with RNA-seq, 362 of 821 were better in the 1000
genomes (129 worse) and 1130 of 2598 were better (371 worse), respectively.
doi:10.1371/journal.pgen.1002144.g002
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biases (Figure S8). We also investigated gained-stop codon variants
for signals of nonsense mediated decay, finding greater than 4-fold
enrichment in exon read count level associations for overlapping
exonswhen comparedto synonymousandnonsynonymous variants
(Figure S9). When assessing this enrichment separately through
ASE signals in the RNA-Seq data, we found that 44% (66 of 150
testable heterozygotes at 32 sites) of stop gained variants where
ASE can be detected are significant compared to only 18.8% of
synonymous variants and 20.9% of nonsynonymous variants.
Cis-regulatory modifiers of protein-coding variants
Regulatory variation can also modify the functional impact
of protein-coding variation. We had previously reported that
18.2% of nonsynonymous variants were modulated by regulatory
variation [25]. We now discovered that at least 20.9% of testable
heterozygotes for nonsynonymous SNPs (n=32859) had signifi-
cantly different expression levels of the two nsSNP alleles (p#0.05;
this is 23.3% for n=38645 when both known alleles are not
required to be observed). This corresponds to 46.2% of non-
synonymous variants having an ASE effect in at least one indi-
vidual (n=5686). These results suggest that regulatory variation
may have a fundamental role in explaining individual differences
in penetrance of disease predisposing variation. Thus, surveys of
coding variation through large-scale exome resequencing studies
[7,26–28] would benefit from complimentary information of regu-
latory variation e.g. from RNA sequencing of the same samples.
Given that regulatory modifiers of protein-coding variation
were prevalent, we looked for population genetic signals of inter-
action between protein-coding and cis regulatory variation. Such
co-evolution would imply a selective advantage of some regulatory
and coding variant combinations over other haplotypes in that
locus potentially increasing linkage disequilibrium (LD). In order
to seek for such patterns from the ASE data, we calculated the
proportion of heterozygous individuals that have significant ASE
as a proxy for linkage disequilibrium between the coding ASE
variant and the unknown regulatory variants. Furthermore, we
used both HM3 and 1KG datasets to control for putative effects of
genotyping error (Figure S10). We observed an increase signal for
nonsynonymous compared to synonymous variants (p=3.5e-4;
Figure S11), which is suggestive coevolution of functional non-
synonymous and regulatory variants. The result is unlikely to be
caused by nonsynonymous SNPs being causal regulatory variants
more often than synonymous SNPs: the two types of variants have
a nearly equal enrichment of exon associations (Figure S9), and
while a change in protein structure might change the overall
expression level of the gene itself through an autoregulatory
mechanism, this is not expected to lead to allelic imbalance. When
stratifying by the derived allele’s expression, in the 1KG data we
observed a large and statistically significant enrichment of the ASE
proportion for rare nonsynonymous variants where the derived
allele has lower expression than the ancestral (Figure S12). This
suggests that some low-frequency deleterious coding variants may
be tolerated in the population only because they lie on a lower
expressed haplotypes and thus have reduced penetrance. This may
be particularly important for understanding the phenotypic effects
of loss-of-function variants – it has been estimated that each person
carries 250 to 300 loss-of-function variants (50 to 100 of which are
previously implicated in inherited disorders) [29], but sometimes
their functional impact may be diminished or strengthened by
their regulatory background.
Detection of rare regulatory variants
Genome sequencing offers the ability to interrogate the func-
tional impact of recent and rare regulatory variants in individuals
[30]. We calculated whether individuals sharing an rare ASE effect
are more likely to show increased haplotype sharing, measured as
haplotype homozygosity, which would be a signal of the ASE
effect being driven by a shared rare regulatory variant (as de-
scribed in [15]). Concordant with previous results, we found an
excess of haplotype sharing for rare ASE haplotypes (Figure S13).
Next, we sought to identify the putative causal variants by
investigating genetic variants which were perfectly concordant
with this rare ASE effect (see Materials and Methods). For each
such effect, we identified a median of 4 and a mean of 8.83
putative regulatory SNPs (prSNPs) within 100 kb of the TSS
(compared to a median of 3 and mean of 7.64 putative regulatory
SNPs under the null; Figure 3 and Figure S14). Altogether, we
identified at least one putative regulatory SNP for 1711 of 2693
genes demonstrating a rare ASE effect (compared to 1517 under
Figure 3. prSNPs detected for rare ASE effects (real and non-ASE). For each ASE effect, we observe more prSNPs for the real ASE versus the
non-ASE null data. On average, we find 1 more prSNP in the real ASE data, which is expected given that the real data should contain at least 1 causal
variant more than the null.
doi:10.1371/journal.pgen.1002144.g003
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20393 under the null). Additionally, the prSNPs showed signs of
increased functional potential compared to the null group: they
were more likely to be distributed around the transcription start
site and within the gene relative to control SNPs (x
2 p-value,2e-16;
Figure S15). Furthermore, the prSNPs were more likely to have a
lower derived allele frequency (p=3.437e-12) and also trended to
have higher evolutionary conservation, indicating that they are
more likely to be functional and putatively slightly deleterious
(p=0.07 with PhyloP vertebrate conservation scores; Figure S16).
We then sought for a signal of rare regulatory variants un-
derlying large changes in gene expression by calculating whether
individuals with outlier array expression values are enriched for rare
genetic variants. We found that individuals with gene expression
Z-score $2 (a measurement of how far the observed value is from
themeanofthesample– seeMaterialsand Methods) haveanexcess
of rare variants within 100 kb of the transcription start site, a signal
that wasstatisticallysignificant(outsidethe 95%CI)forrare variants
landing in highly conserved sites derived from 17-way vertebrate
alignments (Figure 4). The average log-2 difference in expression
from the mean for these variants was 0.7460.52 in CEU and
0.6660.49 in YRI (Figure S17). Overall, there was an excess of 162
coincident singleton,conservedSNPs with expression outliers (Z$2)
inthe CEU sample(one-sided p-value,0.05) and thesame number,
162, in YRI (one-sided p-value,0.05). Divided by the number of
studied individuals, this indicates that there are approximately 3
such effects per individual for this cell type. For other Z-score
thresholds and for RNA-Seq data, we observed the same type of
enrichment (Figures S18 and S19).
Discussion
In this study, we have analyzed common and rare regulatory
variation in the human genome using resequencing data, high-
lighting the many advantages of population-scale sequencing in
understanding the spectrum of functional variation in the genome.
Figure 4. Excess of rare regulatory variants coincident with expression outliers. We calculated the excess of expression outliers as a
function of frequency for all SNPs within 100 kb of the transcription start site of array-quantified genes for both Europeans and Africans. We further
sub-selected to only include SNPs in 17-way most conserved elements from UCSC. We observed an enrichment of conserved singleton SNPs
coincident with expression outliers (Z.2; p,0.05). The confidence intervals were estimated by randomizing expression labels 200 times.
doi:10.1371/journal.pgen.1002144.g004
Rare and Common Regulatory Variation
PLoS Genetics | www.plosgenetics.org 5 July 2011 | Volume 7 | Issue 7 | e1002144The comparison of eQTL discoveries using 1000 genomes and
HapMap 3 data indicated that while many novel associations are
discovered with resequencing data, most of common effects are
already captured with genotyping arrays. Even though mapping
common causal regulatory variants remains a challenge, we
observed a clear enrichment of regulatory effects in splice-site and
nonsense SNPs. Furthermore, we showed that regulatory variation
can putatively modify the effects of a large proportion of non-
synonymous coding variants, and present population genetic
evidence suggestive of such interactions. The possibility to study
rare variants has been one of the main motivations for large-scale
resequencing experiments, and we presented several novel ap-
proaches to analyse rare regulatory variation from genomic as well
as RNA sequencing data. For rare regulatory effects identified
from RNA sequencing data, we were able to pinpoint a median of
four putative regulatory variants per rare effect, one of which is
expected to be causal – a number low enough for feasible
experimental validation. Additionally, individuals with outlying
expression values were shown to have an enrichment of rare
conserved regulatory SNPs, with each individual carrying an
estimation of approximately 3 rare regulatory variants that have a
large effect (Z.=2) on gene expression in the studied cell type.
Across all the tissues and developmental stages, each individual
is expected to have even hundreds of such rare, large effect
regulatory variants. We have also demonstrated how studies
integrating genomic or exome sequencing with RNA sequencing
data from different tissues will also provide information of how
the functional effects of protein-coding variation are modified
by regulatory variation. Altogether, these approaches will bring
us closer to a joint assessment of how genome sequence
affects genome function, and how this relates to phenotypic
diversity.
Materials and Methods
SNP and indel genotypes
We used 1000 genomes polymorphisms from the March 2010
pilot 1 and 2 release (www.1000genomes.org; REL-1003) and
HapMap 3 release 3 genotypes (www.hapmap.org). For associa-
tion analysis, we used 5 404 174 common (MAF$0.05) SNPs for
60 RNA-sequenced CEU individuals (Utah residents with ancestry
from northern and western Europe) and 5 329 982 and 6 976 232
SNPs for 57 and 56 expression-arrayed CEU and Yoruban
individuals (Yoruba in Ibadan, Nigeria), respectively. For two
individuals which were parents in a CEU trio which had variants
independently called in the 1000 genomes (pilot 2), we intersected
their genotype calls with pilot 1 calls; in cases where no genotypes
were reported in the trio individuals, we added the reference
homozygote state. Between pilot 1 and pilot 2, 3 398 517 sites
were concordant and had genotypes reported (for 950 sites the
reference and alternative allele were different between the trio
individuals and the 58 pilot 1 individuals and these sites were
excluded from further processing). For indels, we used calls from
the same release. In total, 592 081, 586 604 and 710 931 common
indels were used in each population sample (60 CEU with RNA-
Seq, 57 CEU with arrays and 56 YRI with arrays). For rare
variant and ASE-based analyses we used only the pilot 1 1000
genomes genotype calls; this was to prevent biases due to the
improved rare variant calling on the pilot 2 trio.
Gene annotation and gene expression data
RNA-sequencing and expression arrays experiments were
performed and quantified on RNA extracted from lymphoblastoid
cell lines as previously reported [15]. We updated our annotation
for RNA-Seq quantification to use the Gencode v3b annotation
[31].
Exon read level associations
For RNA-Seq data, we calculated associations per exon by
quantifying the number of reads overlapping known exon an-
notation for each individual and then performing Spearman rank
correlation with respect to corresponding genotypes as previously
reported [15].
Allele-specific expression analysis
Allele-specific expression was assessed by calculating the allelic
imbalance of variants over heterozygote positions. Significance is
assessed using the binomial probability distribution where the
probability of success is weighted by that individual’s/lane’s
reference allele to non-reference allele mapping bias. ASE
variants used in this study were not monoallelic as we required
both reported alleles to be observed at least once. We also
conditioned on the ASE effect being present for reads quantified
above MAQ10 mapping quality and Phred score of 10 but
subsequently reinforced there was no threshold effect by re-
quiring significance when there was no mapping or base quality
filter.
Fine mapping HapMap3 eQTLs into the 1000 genomes
The best association per gene (or in the case of RNA-Seq data
per exon) at or below the 0.01 permutation threshold was fine-
mapped from the HM3 into the 1KG data. Each of these eQTL
variants from the HM3 was compared to D9 calculated by
Haploview for all the 1KG variants with a Spearman association
of p#10e-3 with the same gene. The 1KG variants which were in
LD (D9$0.8) with the original HM3 variant were deemed to be
underlying the same effect originally discovered in the HM3; the
best association for that gene in the 1KG meeting this LD criterion
was selected for comparison to the original HM3 variant. This
methodology allowed us to survey new discoveries irrespective of
whether they were the same variant, different variants at different
frequencies or divergently-located with respect to the transcription
start site.
Functional variation determination
Functional variation was determined using the EnsEMBL 54
pipeline [32]. Splicing variants were compared to the Gencode
annotation and were deemed accurate for essential splicing
variants if they were within 5 bp of an exon boundary and
accurate for a general splicing variant if they were within 100 bp
of an exon boundary. For testing exon association enrichment,
we took the splicing variant associations for their respective
donor (59) and acceptor (39) exons. To find a matching set to
test for enrichment of association, we considered synonymous
variants which were greater than 15 bp away from an exon
boundary. We calculated enrichment by calculating the qvalue
statistic1-p0 for acceptor and donor associations only when there
were more than 30 associations; the log-ratio of this enrichment
was reported [33]. This calculation was made across the range of
mean read depths for exons from 1–1000 reads. Stop gain
variants were tested against the exon they overlapped and were
also compared in a similar way to synonymous and nonsynon-
ymous mutations.
Conservation and allele-frequency analysis
The PhyloP base-wise conservation scores were based on
alignments of 46 vertebrate genomes, 33 mammalian genomes,
Rare and Common Regulatory Variation
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Ancestral alleles were obtained from the 1000 genomes pilot
release.
Haplotype homozygosity from RNA-Seq data
Haplotype homozygosity indicates the relative age of a haplo-
type by assessing the incidence (or lack thereof) of recombination
or other mutation. This is achieved by comparing the extent of
homozygosity between haplotypes by calculating the length of
sequence from a target marker until a mismatch occurs. Phased
data is required in non-haploid species to assess and compare
individual haplotypes from a target marker position. Furthermore,
since haplotype homozygosity is being assessed from a heterozy-
gous target marker (required for assessing ASE), a decision needs
to be made about what allele should be taken to represent the
reference haplotype and in what direction haplotype homozygosity
should be assessed (59 or 39). Here, we used phasing data as
provided by the 1000 genomes project pilot release and compared
all haplotypes carrying each allele for the heterozygous marker
and in both directions to select the allele and direction with the
average longest tract of haplotype homozygosity. Then, given this
direction and reference haplotype, we take as a criterion for
comparison that there must be at least 6 individuals where
between 2 and 4 have ASE significant haplotypes in the same
direction and at least 2 are non-significant for ASE. To compare
the extent of haplotype homozygosity given the reference
haplotype and the ASE status of each haplotype we compare
significant ASE to significant ASE haplotypes and significant to
non-significant ASE haplotypes and compute the average length of
haplotype homozygosity for all pairwise individual comparisons
within these categories. We then stratify the results for each ASE
marker based on the number of significant ASE haplotypes were
original discovered.
Causal regulatory variant detection for rare regulatory
haplotypes
To identify putative regulatory SNPs on rare regulatory
haplotypes using ASE calculations we looked for all variants
within 100 kb of the transcription start site which satisfied ASE
sharing in 1, 2 or 3 individuals when at least 6 heterozygotes
individuals could be tested for ASE. To satisfy sharing, the variant
must be heterozygous with the same direction of effect (assessed
through phasing) when an ASE effect is present in an individual
and homozygous when the ASE effect is not present. To assess
how well our putative causal regulatory variants discovery was
performing we assessed the distribution of discoveries around the
transcription start site by comparing counts of real predictions
versus control predictions in 5 kb windows using the Fisher’s exact
test (Bonferroni-corrected for multiple testing). Control (null)
predictions were obtained by matching each ASE test by
reassigning significance in the opposite direction. For instance, if
there were 6 heterozygotes, 2 of which show ASE, the control
reassignment would assign ASE to the two least significant
heterozygote individuals. To assign direction of effect, we matched
the distribution of real directions determined with the phasing data
to the control set.
Z-score analysis
We compared the co-occurrence of expression outliers with rare
variants by recomputing our expression files as Z-scores and
binning at each allele frequency the distribution of expression
measurements that were incident with the non-reference variant.
To assess significance of divergence in this distribution, individual
labels were permuted 200 times and 90 and 95% CI were
obtained.
Supporting Information
Figure S1 Comparison of HapMap 3 and 1000 genomes project
eQTL discovery (p-value thresholds). The discovery of eQTLs
from HapMap 3 (black) and 1000 genomes (red) project variants
by expression platform (LCL expression interrogated on arrays
from 56 Africans and 57 Europeans and LCL expression from
RNA sequencing of 60 Europeans) was compared across p-value
thresholds. Here, the equivalent permutation threshold for the
0.01 and 0.001 levels are highlighted. This highlights that the
addition of 5–76 as many markers through whole genome
sequencing is requiring a higher threshold for association sig-
nificance providing the potential to remove many weaker but pre-
viously significant regulatory haplotypes.
(EPS)
Figure S2 Fold changes for significant allele specific expression
variants. We plotted the fold change distribution for significant
ASE variants (p#0.05). The median fold was 1.39. The mean
inter-individual fold change was 1.41 with a standard deviation of
0.16.
(EPS)
Figure S3 Comparison of distance to transcription start site of
fine mapped variants from HapMap3 (HM3) into 1000 genomes
(1KG). An estimate of whether newly discovered associations in
the 1KG are more likely to be causal mutations is to assess their
position relative to the transcription start site (TSS) with the
expectation that causal mutations may be more proximal to the
TSS. We assessed this for array-based and RNA-seq eQTLs and
for each platform we observed that there was no significant trend
towards to the TSS for improved associations. However, we
observed that many of the newly discovered variants are proximal
to the previous reported association from HM3. This supports
that measured eQTLs are not strictly limited to a class that is
influencing the proximal promoter machinery.
(EPS)
Figure S4 Comparison of distance to exon midpoint of fine
mapped variants from HapMap3 (HM3) into 1000 genomes
(1KG). Considering that many newly discovered associations for
the 1KG may be marking genetic differences in splicing or
transcript termination, we interrogated if these associations were
more likely to be discovered proximal to the mid-point of the exon
compared to the original associated variant discovered in HM3.
We assessed the distance to the exon midpoint for exon-eQTLs
discovered in HM3 that were also discovered and in the 1000
genomes. We did not observe a pattern which preferentially
indicated that the new associations were closer to the exon
midpoint. This indicates that in general the improvement in
association is not a function of a particular component of gene
regulatory architecture but is likely a heterogeneous mix of
different genetic effects which influence the transcriptome.
(EPS)
Figure S5 Comparison of distance to transcription start site of
fine mapped variants from HapMap3 (HM3) into 1000 genomes
(1KG) for CpG versus non-CpG promoters. We hypothesized that
the genetic effects on gene expression would be manifested
differently depending on whether a gene’s proximal promoter
contained a CpG island. Our rationale was that CpG promoters
might have broader effect locations while non-CpG and likely
more binding-sequence dependent promoters might be con-
strained closer to the TSS. We did not observe that either had
Rare and Common Regulatory Variation
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prevailing observation was that discovered effects were close to the
original tagging variant in HM3.
(EPS)
Figure S6 Comparison of conservation difference between best
association and second best association within platforms. Given
that the average conservation for HM3 variants was higher than in
1KG (Student’s T-test p,2e-16; MW p,2e-16), we tested if we
saw a larger improvement in conservation score between the best
association and the second best association (conditioned on them
being in D9$0.8). This was matched for the same eQTL as the
HM3 and 1KG best associations were also in D9$0.8. In general,
this was not observed except for YRI (and there only for primate
and not mammalian or vertebrate conservation differences). This
suggests that many of these newly discovered associations in 1KG
are not more highly constrained at the base level then the HM3
associated-variants.
(EPS)
Figure S7 Enrichment of 1000 genomes splicing associations.
To assess the impact of splicing variation identified through
annotation, we assessed the enrichment of associations that we
observed for acceptor versus donor exons stratified by acceptor
(left-panel) and donor snps (right-panel). We plotted this relative
enrichment as a function of mean number of reads per individual
to assess if difference in gene quantities were responsible for
differential discovery of splicing effects.We further also plotted as
the background the same relative enrichment for synonymous
variants which were greater than 15 bp away from the splice
junction and had not be identified as splicing SNPs. We observed
that we could detect enrichment of splicing variation in the RNA-
seq data when sufficient reads were present. This was consistent
specifically for better quantified exons (with sufficient read depth).
This pattern of enrichment for splicing variants is reinforced by
both tests having consistent deviation from the background despite
some observable stochasticity. In this plot, for each binned mea-
sure of enrichment at least 30 variants were available. Enrichment
was measured as the log ratio of the 1-pi0 statistic for acceptor
versus donor exon associations (using q-value statistics).
(EPS)
Figure S8 Enrichment of 1000 genomes splicing associations
without mapping filter. To address if the enrichment of splicing
variants we observed was due to threshold effects due to mapping
we removed mapping quality filters and repeated the same analy-
sis. For both acceptor and donor variants we observed the same
enrichment relative to synonymous variants.
(EPS)
Figure S9 Enrichment of exon-eQTLs for overlapping exons of
synonymous, nonsynonymous and gained stop variants. We
observed significant enrichment for exon-eQTLs for gained stop
variants when compared to enrichment we observed for synony-
mous and nonsynonymous variants. This enrichment suggests that
nonsense mediated decay is detectable in RNA-Seq data. The level
of enrichment was estimated using the 1-pi0 statistic.
(EPS)
Figure S10 Proportion of ASE of all heterozygotes per variant
with respect to derived allele frequency. To investigate the
relationship between regulatory and coding variation we looked
at the proportion of heterozygotes which had allele specific
expression (ASE). This proportion is expected to be high when the
coding variant is in strong linkage with a cis-regulatory variant
causing the allelic imbalance. We calculated the proportion of
ASE with respect to DAF for cSNPs with ASE and at least 3
heterozygotes in the full 1KG data (a), in 1KG SNPs with both
allele observed at least once (b), and in SNPs with genotypes
concordant with HM3 data (c). The dark blue lines are means in
sliding windows of 600, 400 and 150 SNPs respectively,
proportionally to the number of SNPs, and the cyan lines denote
the 10% upper and lower quantiles. The analysis was performed
for these three datasets to control for possible effects of false
heterozygote genotype calls in the 1KG data. However, it is
frequent that only one allele is observed in the RNA-Seq data even
when analyzing the high-quality heterozygotes from the HM3
dataset (2042 of 6859 (30%) of ASE heterozygotes). This
proportion was higher in the full 1KG data (41%, 21122/
51585), which could be caused by genotyping error. However,
false ASE calls are likely to create single random ASE observations
per SNP and decrease the mean ASE proportion; thus, our
analysis looking of an increase is likely to be conservative in this
respect. Altogether, the results show increased ASE proportion in
the end of the DAF distribution. This can arise by chance through
new regulatory mutations landing on haplotypes carrying a rare
coding allele, or a new coding mutations landing on haplotypes
carrying a rare regulatory allele. Additionally, even co-evolution-
ary pressure on a haplotypes containing both variants can increase
the proportion of ASE.
(EPS)
Figure S11 Proportion of ASE of all heterozygotes per variant
for synonymous and nonsynonymous variants. For sSNPs and
nsSNPs with ASE and at least 3 heterozygotes in the full 1KG
data (a), in 1KG SNPs with both allele observed at least once (b),
and in SNPs with genotypes concordant with HM3 (c), we
observed that that the proportion of ASE is higher for non-
synonymous than synonymous variants. This may suggest
increased LD between regulatory variants and nsSNPs through
favoring of functional coding variants on a particular regulatory
haplotype over other haplotype combinations. Significance was
assessed using Mann-Whitney.
(EPS)
Figure S12 Mean proportion of ASE of all heterozygotes with
respect to derived allele frequency for synonymous and nonsynon-
ymous variants where the derived allele is higher or lower
expressed. The proportion of heterozygote individuals with ASE
was separated by derived allele’s expression (either ‘‘loss’’ or
‘‘gain’’) for sSNPs and nsSNPs with ASE and at least 3 hetero-
zygotes in the full 1KG data (a), in 1KG SNPs with both allele
observed at least once (b), and in SNPs with genotypes concordant
with HM3 (c). The lines are means in sliding windows of 300, 200
and 75 SNPs respectively, proportionally to the number of SNPs,
and the Mann-Whitney p-values for sSNPs versus nsSNPs have
been calculated in DAF bins of 0.05 with an overlap of 0.025. The
proportion of ASE is high especially in rare nonsynonymous
variants where the derived allele is lower expressed, potentially
suggesting evolutionary preference of rare derived nsSNP alleles to
be on the lower expressed haplotype. This could be a signal of rare
deleterious coding variants that are tolerated in the population due
to being on a lower expressed haplotype, which lowers their
penetrance. The trend can be seen also in the 1KG data with both
alleles observed but is expectedly weaker, since this phenomenon
would be strongest when the rare derived allele is hardly expressed
at all. The lack of signal in HM3 may be explained by these
variants being underrepresented in the SNP genotyping arrays.
(EPS)
Figure S13 Extent of haplotype homozygosity for shared
ASE effects. To identify signals of recent and rare eQTLs in
the 1000 genomes data, we assessed the extent of haplotype
Rare and Common Regulatory Variation
PLoS Genetics | www.plosgenetics.org 8 July 2011 | Volume 7 | Issue 7 | e1002144homozygosity for shared ASE individuals versus ASE and non-ASE
individuals (when there was greater than 6 heterozygotes individuals
which were quantifiable for ASE and a significant ASE effect was
observed in 2,3 or 4). We observed that when ASE was shared
among 2 or 3 individuals, there were longer tracks of haplotype
homozygosity indicating shared genealogy for an underlying causal
mutation. This result supports previous findings we observed using
HapMap3 phasing data (Montgomery et al, 2010).
(EPS)
Figure S14 Number of prSNPs detected for real ASE and non-
ASE effects. We plotted the distribution of the number of real
prSNPs from control prSNPs detected for each ASE effect. Here,
at each testable marker, the number of real prSNPs is subtracted
from the number of control prSNPs identified and plotted as a
histogram. The shift to the left shows that many more ASE effects
have more real prSNPs than control prSNPs.
(EPS)
Figure S15 prSNPs distributed around the transcription start
site. We assessed the location of prSNPs discovered for the real
versus non-ASE predictions. We found many of the real pre-
dictions where centred around the transcription start site and
downstream within the respective gene. The difference in this
distribution was highly significant (x
2 p-value,2e-16). Bins where
there were significant prediction differences using a Bonferroni-
corrected Fisher’s exact test are highlight by stars. This result
indicates that many real prSNPs are located within the gene or
near promoters and suggests that the predictions are preferentially
targeting regions with a higher prior of functionality.
(EPS)
Figure S16 Real prSNPs are more conserved and have lower
derived allele frequency. We compared evolutionary constraint
and derived allele frequency for prSNPs versus control SNPs and
found that the prSNPs trended towards being slightly more
conserved (PhyloP primate base conservation p=0.12 MW;
PhyloP mammalian base conservation p=0.09; PhyloP vertebrate
base conservation p=0.07) and were more likely to have lower
derived allele frequency (p=3.437e-12 MW). This suggests that
the prSNPs are more likely targeting functional sequence and are
more likely to be slightly deleterious.
(EPS)
Figure S17 log2 difference from mean for Z.2 conserved
singleton variants. The distribution of expression differences for
conserved singleton Z.2 variants was plotted to observe the
average effect size of these variants. Approximately 4/5
th of these
variants are expected by chance. However, large differences can
also be observed and are candidates for bonafide rare variants
which have important effects. Of note, the CEU variants also
appear enriched for expression differences relative to YRI.
(EPS)
Figure S18 Observed coincident array expression outliers by
expected number for singletons. For singletons, we plot the
number of expected coincident outliers at a particular Z-score
(calculated by running 200 permutations of the expression
individual labels) versus the observed number (black line). Where
the difference is greater than 5% of all permuted observations, a
red dot is marked and the number of effects per individual is
tabulated. Here, we observe, consistent with results summarized in
Figure 4, that YRI enrichment is more significant than the CEU.
However, this plot indicates that this enrichment is across the Z-
score spectrum. It should be noted that CEU SNPs are significant
for Z.=2 in this plot while the CEU SNPs did not exceed the 5%
CI bound in Figure 4; this is because there we used a two-sided
bound, whereas in this plot, we are using a one-sided estimate of
significance since our expectation is that there will be an excess of
effects. The significance for the excess for CEU SNPs is marginal
though at disappears if we require the observed to be greater than
2.5% of all permuted observations.
(EPS)
Figure S19 Observed coincident RNA-seq expression outliers by
expectednumberforsingletons.ForCEURNA-Seq dataweobserve
a similar pattern of enrichment for conserved singletons being
outliersas we observe in the array data(Figure S18).Herewe chosea
smaller window size than we used for arrays to reduce the number of
tests and increase signal (50 kb instead of 100 kb around the
transcription start site). However, we find slightly fewer effects than
the arrays. This islikely due to the factwe arestill testing a factor of 2
more expression measurements and the RNA-Seq experiment may
contain more stochasticity for any individual estimate of exon read
countlevel.Weexpectthatasweimprovewithinindividualestimates
ofspecifictranscript levels,wemayfindthe RNA-Seqdata willbetter
uncover many more rare variant effects.
(EPS)
Table S1 Associated variantdiscovery from 1000 genomes (1KG)
to HapMap 3 (HM3). EQTL variants discovered in the 1KG (best
associated variant at 0.01 permutation threshold per gene) were
compared to their equivalent discovery in HM3. Only 1/5 of these
1KG eQTLs were found in the HM3 and passed its equivalent
significance threshold. Approximately 2% were in the HM3 but fell
belowthisthreshold indicating eithergenotypeerrorinthe HM3or,
less likely, stochastic improvement in association due to genotyping
error in the 1KG. The remaining 4/5 of the association are for new
markers that were not assayed in the HM3. This indicates that if
these new variants are bonafide causal variants, whole genome
sequencing is uncovering a large number that had previously not
been identified. *Independent eQTLs defined by recombination
interval and LD filtering as previously reported in [35].
(DOCX)
Table S2 Associated variant discovery from HapMap 3 (HM3)
to 1000 genomes (1KG). EQTL variants discovered in HM3 (best
associated variant at 0.01 permutation threshold per gene) were
compared to their equivalent discovery in 1KG. Approximately 2/
5 of the associations genotyped in both passed the equivalent
discovery thresholds. Approximately 3/5 of the associations did
not pass the discovery threshold in 1KG indicating that the extra
multiple testing correction of the many extra variants gained
through whole genome sequencing is masking some eQTLs. Only
a marginal fraction of the associated SNPs were not found in the
1KG. *Independent eQTLs defined by recombination interval
and LD filtering as previously reported in Nica et al. [Nica AC,
Parts L, Glass D, Nisbet J, Barrett A, et al. (2011) The Architecture
of Gene Regulatory Variation across Multiple Human Tissues:
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